We analyzed heart variability (HRV) response to tilt in 35 patients with a history of neurocardiogenic syncope and in 8 normal volunteers. Frequency domain examination was performed using power spectral analysis of RR variability during resting supine position and during the 256 beats preceding the onset of syncope or completion of 60 min of upright tilt to 70°. Both low (0.05-0.15 Hz) and high frequency (0.15-0.4 Hz) spectral components of HRV increased markedly in all groups as a result of tilting. Statistically significant differences were noted between the patient groups at completion of upright tilting. However, these differences in spectral components between groups were of small magnitude when compared to the overall increase in spectral power occurring in all groups as a result of the tilt and are difficult to correlate clinically with the appearance, or lack of appearance of tilt-induced syncope. Power spectral analysis of HRV, as presently performed, appears to lack discriminative power to detect the rapid and marked changes in sympathovagal modulation known to occur during tilt test in patients with neurocardiogenic syncope.

Keywords:
Syncope, Heart rate, Autonomic nervous system, Sympathetic nervous system, Parasympathetic nervous system
This content is only available via PDF.
© 1996 S. Karger AG, Basel
1996
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.